Skip to main content

Indivior Pharmaceuticals, Inc.

INDV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001625297

In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.

13F holders, Q2 2025

Institutional positions in Indivior Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
120
+5 vs. Q1 2025
Shares held
107.0M
+16.5M (+18.2%) vs. Q1 2025
Total value
$1.58B
+$719.8M (+83.9%) vs. Q1 2025
New holders
37
44 more added
Sold out
32
24 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INDV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 120 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 60 institutionsQ3 2023: 76 institutionsQ4 2023: 76 institutionsQ1 2024: 95 institutionsQ2 2024: 99 institutionsQ3 2024: 103 institutionsQ4 2024: 113 institutionsQ1 2025: 116 institutionsQ2 2025: 120 institutionsQ3 2025: 198 institutionsQ4 2025: 259 institutionsQ1 2026: 290 institutionsQ2 2026: 337 institutions
Value heldQ2 2025: $1.58B
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $1.46BQ3 2023: $1.53BQ4 2023: $974.7MQ1 2024: $1.38BQ2 2024: $1.03BQ3 2024: $720.7MQ4 2024: $974.8MQ1 2025: $866.0MQ2 2025: $1.58BQ3 2025: $2.68BQ4 2025: $4.36BQ1 2026: $3.89BQ2 2026: $4.98B
Institutions holding INDV and their total value by quarter
QuarterHoldersValue
Q2 2026337$4.98B
Q1 2026290$3.89B
Q4 2025259$4.36B
Q3 2025198$2.68B
Q2 2025120$1.58B
Q1 2025116$866.0M
Q4 2024113$974.8M
Q3 2024103$720.7M
Q2 202499$1.03B
Q1 202495$1.38B
Q4 202376$974.7M
Q3 202376$1.53B
Q2 202360$1.46B
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Indivior Pharmaceuticals, Inc.; share changes are against Q1 2025.

Institutions holding INDV in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Acadian Asset Management LLC1,492,272$22.0M0.05%+827,230+124.4%Added
State Street Corp1,570,341$23.1M0.00%+1,570,341New
Geode Capital Management, LLC1,576,915$23.2M0.00%+1,447,939+1,122.6%Added
Scopia Capital Management LP1,654,855$24.4M2.98%−220,253−11.7%Reduced
Barclays PLC2,099,060$30.9M0.01%+756,579+56.4%Added
Jefferies Financial Group Inc.2,190,274$32.5M0.54%+708,941+47.9%Added
Mangrove Partners2,272,668$33.5M3.60%+1,559,870+218.8%Added
UBS Group AG2,387,990$35.2M0.01%−1,139,289−32.3%Reduced
Newtyn Management, LLC2,607,018$38.4M5.82%+956,080+57.9%Added
Millennium Management LLC3,396,913$50.1M0.04%+931,199+37.8%Added
Point72 Asset Management, L.P.3,572,859$52.7M0.12%+1,686,628+89.4%Added
Rubric Capital Management LP4,647,179$68.5M1.10%+1,117,140+31.6%Added
BlackRock, Inc.5,684,578$83.8M0.00%+5,617,001+8,312.0%Added
Vanguard Group Inc5,647,309$83.9M0.00%+1,016,088+21.9%Added
Madison Avenue Partners, LP7,922,178$116.8M7.80%+130,089+1.7%Added
Goldman Sachs Group Inc9,564,091$141.0M0.02%+1,195,095+14.3%Added
Deerfield Management Company, L.P. (Series C)10,567,160$155.8M2.83%00.0%Unchanged
Oaktree Capital Management LPSuperinvestorOaktree Capital11,009,125$162.3M3.22%00.0%Unchanged
Two Seas Capital LP11,407,795$168.2M16.49%+41,018+0.4%Added
Bank of Montreal901––+37+4.3%Added
Weiss Asset Management LP0$00.00%−465,048−100.0%Sold out
Fund 1 Investments, LLC0$00.00%−427,439−100.0%Sold out
Marshall Wace, LLP0$00.00%−394,841−100.0%Sold out
Verition Fund Management LLC0$00.00%−275,088−100.0%Sold out
HRT Financial LP0$00.00%−254,685−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−239,389−100.0%Sold out
Squarepoint Ops LLC0$00.00%−201,577−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−185,000−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−178,825−100.0%Sold out
Jain Global LLC0$00.00%−146,507−100.0%Sold out
LMR Partners LLP0$00.00%−88,783−100.0%Sold out
Quantessence Capital LLC0$00.00%−84,812−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−66,271−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−54,321−100.0%Sold out
XTX Topco Ltd0$00.00%−50,437−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−50,210−100.0%Sold out
Diametric Capital, LP0$00.00%−49,838−100.0%Sold out
Janus Henderson Group PLC0$00.00%−40,546−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−30,734−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−26,758−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−24,480−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−20,700−100.0%Sold out
HSBC Holdings PLC0$00.00%−15,823−100.0%Sold out
CJM Wealth Advisers, Ltd.0$00.00%−13,100−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−12,037−100.0%Sold out
CTC Alternative Strategies, Ltd.0$00.00%−10,100−100.0%Sold out
Cannon Global Investment Management, LLC0$00.00%−10,000−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−7,767−100.0%Sold out
Optiver Holding B.V.0$00.00%−6,513−100.0%Sold out
Lazard Asset Management LLC0$00.00%−339−100.0%Sold out
Guardian Wealth Management, Inc.0$00.00%−160−100.0%Sold out
Hexagon Capital Partners LLC0$00.00%−12−100.0%Sold out
Credit Agricole S A––––Not filed